Literature DB >> 7212759

Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.

H Frisch, K Parth, E Schober, W Swoboda.   

Abstract

In 11 children aged between 2 and 17 years with (nonsalt-losing) congenital adrenal hyperplasia (21-hydroxylase deficiency) blood was drawn at 90-minute intervals during a 24-hour period and levels of 17-hydroxyprogesterone, testosterone, and cortisol were measured. Levels of 17-ketosteroids and pregnanetriol were measured too in 24-hour urine samples. These measurements were taken under different regimens of treatment and after interruption of treatment. Cortisol level rose and fell rapidly after administered corticosteroid, and reached unphysiologically high levels. Testosterone levels showed pronounced variations but stayed in the normal range for most of the time even in untreated patients; thus testosterone provides a poor control parameter. Levels of 17-hydroxyprogesterone showed extreme fluctuations and very high peak levels in untreated patients; standard treatment with two or three daily doses of corticosteroids did not prevent a pronounced rise in its level after midnight. After the first morning dose of hydrocortisone a very steep fall was observed. The 24-hour pregnanetriol excretion correlated well with the corresponding total integrated 17-hydroxyprogesterone area. It is concluded that single 17-hydroxyprogesterone values are unlikely to give adequate information about the quality of treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7212759      PMCID: PMC1627169          DOI: 10.1136/adc.56.3.208

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Blood testosterone values in patients with congenital virilizing adrenal hyperplasia.

Authors:  I L Solomon; E J Schoen; L Donelan; D Brandt-Erichsen
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

2.  [17-hydroxyprogesterone, testosterone and androstenedione in treated congenital adrenogenital syndrome].

Authors:  K von Schnakenburg; F Bidingmaier; D Knorr
Journal:  Monatsschr Kinderheilkd       Date:  1977-05

3.  The simultaneous assay of cortisol and 17alpha-hydroxyprogesterone in the plasma of patients with congenital adrenal hyperplasia.

Authors:  M T Pham-Huu-Trung; M Gourmelen; F Girard
Journal:  Acta Endocrinol (Copenh)       Date:  1973-10

4.  Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.

Authors:  N D Barnes; S M Atherden
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

5.  Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.

Authors:  B M Lippe; S H LaFranchi; N Lavin; A Parlow; J Coyotupa; S A Kaplan
Journal:  J Pediatr       Date:  1974-12       Impact factor: 4.406

6.  Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.

Authors:  S M Atherden; N D Barnes; D B Grant
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

7.  Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.

Authors:  T J McKenna; A S Jennings; G W Liddle; I M Burr
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

8.  Treatment of congenital virilizing adrenal hyperplasia patients with single and multiple daily doses of prednisone.

Authors:  C A Huseman; M M Varma; R M Blizzard; A Johanson
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

9.  Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia.

Authors:  C A Strott; T Yoshimi; M B Lipsett
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808

10.  The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.

Authors:  I A Hughes; J S Winter
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

View more
  17 in total

1.  Monitoring treatment in congenital adrenal hyperplasia.

Authors:  S Appan; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

2.  Clinical manifestations and hormonal profile of two women with Cushing's disease and mild deficiency of 21-hydroxylase.

Authors:  M Boronat; A Carrillo; A Ojeda; J Estrada; B Ezquieta; F Marín; F J Nóvoa
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

3.  Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia.

Authors:  I N Silva; C E Kater; C F Cunha; M B Viana
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

4.  Circadian patterns of plasma steroids in congenital adrenal hyperplasia.

Authors:  I A Hughes
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

5.  [Problems and characteristics of the orthodontic treatment of a patient with adrenogenital syndrome].

Authors:  J W Schlupper-Beckmann; M Lücke; R Mallmann
Journal:  Fortschr Kieferorthop       Date:  1989-10

6.  Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.

Authors:  Kyriakie Sarafoglou; John H Himes; Jean M Lacey; Brian C Netzel; Ravinder J Singh; Dietrich Matern
Journal:  Horm Res Paediatr       Date:  2010-08-25       Impact factor: 2.852

7.  Plasma renin activity in the management of congenital adrenal hyperplasia.

Authors:  K D Griffiths; J M Anderson; B T Rudd; N K Virdi; G Holder; P H Rayner
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

8.  Duration of suppression of adrenal steroids after glucocorticoid administration.

Authors:  John S Fuqua; Deborah Rotenstein; Peter A Lee
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-31

9.  Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.

Authors:  J Sólyom
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

10.  170H-progesterone rhythms in congenital adrenal hyperplasia.

Authors:  M C Young; J A Robinson; G F Read; D Riad-Fahmy; I A Hughes
Journal:  Arch Dis Child       Date:  1988-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.